MENU
+Compare
AVNS
Stock ticker: NYSE
AS OF
Jul 21, 04:59 PM (EDT)
Price
$11.41
Change
+$0.19 (+1.69%)
Capitalization
919.92M

AVNS Avanos Medical Forecast, Technical & Fundamental Analysis

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally... Show more

AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AVNS with price predictions
Jul 18, 2025

AVNS sees MACD Histogram crosses below signal line

AVNS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 11, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AVNS as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AVNS moved below its 50-day moving average on July 02, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AVNS entered a downward trend on July 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNS advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.732) is normal, around the industry mean (24.694). P/E Ratio (51.865) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.356) is also within normal values, averaging (43.458).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVNS is expected to report earnings to fall 42.31% to 15 cents per share on August 12

Avanos Medical AVNS Stock Earnings Reports
Q2'25
Est.
$0.15
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.05
The last earnings report on May 06 showed earnings per share of 25 cents, beating the estimate of 18 cents. With 135.36K shares outstanding, the current market capitalization sits at 919.92M.
A.I. Advisor
published General Information

General Information

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5405 Windward Parkway
Phone
+1 844 428-2667
Employees
3771
Web
https://www.avanos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGGKX30.290.11
+0.36%
Baillie Gifford US Equity Growth K
DFGEX10.750.02
+0.19%
DFA Global Real Estate Securities Port
SCAUX11.520.01
+0.09%
Invesco Income Advantage U.S. Fund A
PDECX17.15-0.05
-0.29%
PGIM Jennison Emerging Markets Eq Opps C
GACIX46.33-0.30
-0.64%
Gabelli Small Cap Growth I

AVNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with TMCI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-3.61%
TMCI - AVNS
43%
Loosely correlated
-2.42%
STE - AVNS
43%
Loosely correlated
+0.44%
UFPT - AVNS
43%
Loosely correlated
-1.75%
UTMD - AVNS
42%
Loosely correlated
-0.89%
CNMD - AVNS
42%
Loosely correlated
-3.27%
More